Elan

Contact
elan.com
+353-1-709-4444

Elan Corporation plc

Treasury Building, Lower Grand Canal Street
2 Dublin
Ireland
+353-1-709-4444
elan.com
Contact
Profile News
Contact

About Elan

Elan Corporation, plc is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and severe pain.

Read more about Elan
Facts about Elan
  • Focus : Manufacturer
  • Industry : Pharma

News about Elan

Elan

16-Mar-2010 | business & finance

Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT From Elan

Azur Pharma Limited announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) to acquire the ...

Read news
Elan

27-Jan-2009 | business & finance

Graffinity and Elan launch fragment-based drug discovery collaboration

Graffinity Pharmaceuticals GmbH announced that it has entered into a research collaboration with Elan Pharmaceuticals, Inc., a subsidiary of Elan ...

Read news
Elan

22-Oct-2008 | research and development

Elan and Transition Therapeutics Achieve Patient Enrollment Target in Phase 2 Clinical Study of ELND005 (AZD-103)

Elan Corporation, plc and Transition Therapeutics Inc. announced the achievement of the patient enrollment target for a Phase 2 clinical study of ELND005 ( ...

Read news
Elan

08-Sep-2008 | research and development

Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI in Oncology

Elan Corporation, plc and Biogen Idec announced the initiation of the first clinical trial of TYSABRI® (natalizumab) in oncology. The first dose of ...

Read news
Elan

31-Aug-2007 | research and development

Transition Therapeutics Announces Completion of Phase I Clinical Studies with Alzheimer's Disease Drug Candidate

Transition Therapeutics Inc. announced the completion of Phase I clinical studies with Alzheimer's disease drug candidate ELND-005/AZD-103. Transition and ...

Read news
Elan

22-Aug-2007 | research and development

TYSABRI Demonstrates Significant Health-Related Quality-of-Life Improvements for Multiple Sclerosis Patients

Biogen Idec and Elan Corporation, plc announced the publication of results demonstrating that patients treated with TYSABRI(R) (natalizumab) showed a ...

Read news
Elan

10-Apr-2007 | research and development

FDA Grants Fast Track Designation to Alzheimer's Disease Drug Candidate AZD-103/ELND005

Transition Therapeutics Inc. announced that the United States Food and Drug Administration has granted Fast Track designation to investigational drug ...

Read news
Elan

04-Oct-2006 | business & finance

Elan and Transition Therapeutics Inc. Announce Global Collaboration to Develop and Commercialize Alzheimer's Disease Drug AZD-10

Elan Corporation, plc and Transition Therapeutics Inc. announced an exclusive, worldwide collaboration agreement for the joint development and commercializa ...

Read news
Show more news about Elan

Here you will find Elan Corporation plc